Facet Biotech
Steve Keller has worked for several companies in the field of bioanalytical sciences. Steve began their career at Bartels Diagnostics, Baxter Healthcare as a Research Scientist/Supervisor of Assay Development from 1986 to 1990. Steve then joined PDLBioPharma as a Director of Bioanalytical Sciences in 1997, and remained in this role until at least 2006. In 2008, they moved to Facet Biotech where they also held the position of Director of Bioanalytical Sciences. The exact end dates for their roles at PDLBioPharma and Facet Biotech are not provided.
Steve Keller obtained a Bachelor of Science degree in Physiology from the University of California, Davis, where they studied from 1981 to 1986. Steve later pursued higher education at the University of Utah, completing their PhD in Human Genetics from 1990 to 1996.
This person is not in any teams
Facet Biotech
With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company. Combining our expertise in antibody engineering with a disciplined, biology-driven research approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.